drugset / Trial / NCT03658876

Predictors of Response to Iron and Erythropoietin Stimulating Agents

NCT03658876

Phase 4 Completed 197 enrolled Imperial College London
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of the study is to identify predictors of treatment response. This involves collected baseline clinical parameters and bloods for biochemical parameters prior to administering the study treatment. A positive outcome following treatment was defined as an uptitration of haemoglobin by greater than 5g/l within 2 months. The study evaluated the participants response to treatment against the clinical and biochemical information collected prior to treatment being received.

Timeline

Start
2015-06-03
Primary completion
2016-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron sucrose Unknown 200 mg
Comparator epoetin alfa Protein / enzyme biologic 0 iu
Comparator epoetin alfa Protein / enzyme biologic 1000 iu
Comparator epoetin alfa Protein / enzyme biologic 2000 iu
Comparator epoetin alfa Protein / enzyme biologic 3000 iu
Comparator epoetin alfa Protein / enzyme biologic 4000 iu
Comparator epoetin alfa Protein / enzyme biologic 6000 iu
Comparator epoetin alfa Protein / enzyme biologic 8000 iu
Comparator epoetin alfa Protein / enzyme biologic 12000 iu